Effect of tocolytic drugs on fetal heart rate variability: a systematic review - PubMed (original) (raw)
Review
. 2017 Oct;30(20):2387-2394.
doi: 10.1080/14767058.2016.1249844. Epub 2016 Nov 8.
Affiliations
- PMID: 27756155
- DOI: 10.1080/14767058.2016.1249844
Free article
Review
Effect of tocolytic drugs on fetal heart rate variability: a systematic review
Kim M J Verdurmen et al. J Matern Fetal Neonatal Med. 2017 Oct.
Free article
Abstract
Introduction: Tocolytics may cause changes in fetal heart rate (HR) pattern, while fetal heart rate variability (HRV) is an important marker of fetal well-being. We aim to systematically review the literature on how tocolytic drugs affect fetal HRV.
Materials and methods: We searched CENTRAL, PubMed and EMBASE up to June 2016. Studies published in English, using computerized or visual analysis to describe the effect of tocolytics on HRV in human fetuses were included. Studies describing tocolytics during labor, external cephalic version, pre-eclampsia and infection were excluded. Eventually, we included six studies, describing 169 pregnant women.
Results: Nifedipine, atosiban and indomethacin administration show no clinically important effect on fetal HRV. Following administration of magnesium sulfate decreased variability and cases of bradycardia are described. Fenoterol administration results in a slight increase in fetal HR with no changes in variability. After ritodrine administration increased fetal HR and decreased variability is seen. The effect of co-administration of corticosteroids should be taken into account.
Conclusion: In order to prevent iatrogenic preterm labor, the effects of tocolytic drugs on fetal HRV should be taken into account when monitoring these fetuses.
Keywords: Tocolytic therapy; beta-adrenergic agonist; calcium channel blocker; fetal heart rate variability; oxytocin receptor antagonist; prostaglandin antagonist.
Similar articles
- Fetal bradycardia secondary to magnesium sulfate therapy for preterm labor. A case report.
Hamersley SL, Landy HJ, O'Sullivan MJ. Hamersley SL, et al. J Reprod Med. 1998 Mar;43(3):206-10. J Reprod Med. 1998. PMID: 9564647 - Magnesium sulfate, maternal hypothermia, and fetal bradycardia with loss of heart rate variability.
Cardosi RJ, Chez RA. Cardosi RJ, et al. Obstet Gynecol. 1998 Oct;92(4 Pt 2):691-3. doi: 10.1016/s0029-7844(98)00212-9. Obstet Gynecol. 1998. PMID: 9764667 - Effect of magnesium sulfate on fetal heart rate patterns in the second stage of labor.
Duffy CR, Odibo AO, Roehl KA, Macones GA, Cahill AG. Duffy CR, et al. Obstet Gynecol. 2012 Jun;119(6):1129-36. doi: 10.1097/AOG.0b013e318257181e. Obstet Gynecol. 2012. PMID: 22617576 - Risk-benefit effects of tocolytic therapy.
Pryde PG, Janeczek S, Mittendorf R. Pryde PG, et al. Expert Opin Drug Saf. 2004 Nov;3(6):639-54. doi: 10.1517/14740338.3.6.639. Expert Opin Drug Saf. 2004. PMID: 15500422 Review. - [Effect of maternal pharmacological treatment of preterm delivery for neonatal condition].
Kornacka MK. Kornacka MK. Med Wieku Rozwoj. 2003 Jul-Sep;7(3 Suppl 1):115-21. Med Wieku Rozwoj. 2003. PMID: 15537251 Review. Polish.
Cited by
- Novel Tocolytic Strategy: Modulating Cx43 Activity by _S_-Nitrosation.
Barnett SD, Asif H, Anderson M, Buxton ILO. Barnett SD, et al. J Pharmacol Exp Ther. 2021 Mar;376(3):444-453. doi: 10.1124/jpet.120.000427. Epub 2020 Dec 31. J Pharmacol Exp Ther. 2021. PMID: 33384302 Free PMC article. - Changes in Maternal Heart Rate Variability in Response to the Administration of Routine Obstetric Medication in Hospitalized Patients: Study Protocol for a Cohort Study (MAMA-Heart Study).
Bester M, Moors S, Joshi R, Nichting TJ, van der Hout-van der Jagt MB, Oei SG, Mischi M, Vullings R, van Laar JOEH. Bester M, et al. Clin Pract. 2021 Jan 21;11(1):13-25. doi: 10.3390/clinpract11010004. Clin Pract. 2021. PMID: 33599215 Free PMC article. - The electrical heart axis of the fetus between 18 and 24 weeks of gestation: A cohort study.
Lempersz C, Noben L, Clur SB, van den Heuvel E, Zhan Z, Haak M, Oei SG, Vullings R, van Laar JOEH. Lempersz C, et al. PLoS One. 2021 Dec 16;16(12):e0256115. doi: 10.1371/journal.pone.0256115. eCollection 2021. PLoS One. 2021. PMID: 34914710 Free PMC article. Clinical Trial. - Barusiban, a selective oxytocin receptor antagonist: placental transfer in rabbit, monkey, and human†.
Helmer H, Saleh L, Petricevic L, Knöfler M, Reinheimer TM. Helmer H, et al. Biol Reprod. 2020 Jun 23;103(1):135-143. doi: 10.1093/biolre/ioaa048. Biol Reprod. 2020. PMID: 32307542 Free PMC article. - A Review on the Vagus Nerve and Autonomic Nervous System During Fetal Development: Searching for Critical Windows.
Cerritelli F, Frasch MG, Antonelli MC, Viglione C, Vecchi S, Chiera M, Manzotti A. Cerritelli F, et al. Front Neurosci. 2021 Sep 20;15:721605. doi: 10.3389/fnins.2021.721605. eCollection 2021. Front Neurosci. 2021. PMID: 34616274 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources